Usefulness of 18F-fluorodeoxyglucose PET for radiosurgery planning and response monitoring in patients with recurrent spinal metastasis

Minimally Invasive Neurosurgery

Volumn 49, Issue 3, 2006, Pages 127-134

  Gwak, H S ^a   Youn, S M ^a   Chang, U ^a   Lee, D H ^a   Cheon, G J ^a   Rhee, C H ^a   Kim, K ^b   Kim, Hyun Jib ^b,c  

^a Korea Institute of Radiation and Medical Science   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Seoul National University Bundang Hospital   (South Korea)

Author keywords

FDG PET; Planning; Radiosurgery; Recurrence; Spinal metastasis; Treatment response

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; BREAST CANCER; CASE REPORT; FEMALE; FOLLOW UP; HEADACHE; HUMAN; MALE; MONITORING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MEDICINE; PATIENT COMPLIANCE; POSITRON EMISSION TOMOGRAPHY; RADIATION DOSE; RADIOSURGERY; RECURRENT DISEASE; SARCOMA; SPINAL CORD METASTASIS; STEREOTAXIC SURGERY; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT PLANNING; TUMOR VOLUME; VERTEBRA BODY;

ADULT; BREAST NEOPLASMS; CERVICAL VERTEBRAE; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RADIOSURGERY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; SARCOMA; SPINAL NEOPLASMS; THORACIC VERTEBRAE;

EID: 33746561775     PISSN: 09467211     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-932181     Document Type: Article

References (30)

1. Bunger C, Laursen M, Hansen ES, Neumann P, Christensen FB, Hoy K, Helmig P. A new algorithm for the surgical treatment of spinal metastases. Curr Opin Orthop 1999; 10: 101-105
2. Camins MB, Jenkins 3rd AL, Singhal A, Perrin RG. Tumors of the vertebral axis: benign, primary malignant, and metastatic tumors. In: Winn HR (ed). Youmans neurological surgery, volume 4, fifth edition. Philadelphia: Elsevier Inc, 2002: 4835-4868
3. Schiff D, Shaw EG, Cascino TL. Outcome after spinal reirradiation for malignant epidural spinal cord compression. Ann Neurol 1995; 37: 583-589
4. Hamilton AJ, Lulu BA, Fosmire H, Gossett L. LINAC-based spinal stereotactic radiosurgery. Stereotact Funct Neurosurg 1996; 66: 1-9
5. Adler Jr JR, Murphy MJ, Chang SD, Hancock SL. Image guided robotic radiosurgery. Neurosurgery 1999; 44: 1299-1306
6. Murphy MJ, Adler Jr JR, Bodduluri M, Dooley J, Forster K, Hai J, Le Q, Luxton G, Martin D, Poen J. Image-guided radiosurgery for the spine and pancreas. Comp Aid Surg 2000; 5: 278-288
7. Ryu SI, Chang SD, Kim DH, Murphy MJ, Le QT, Martin DP, Adler Jr JR. Image-guided hypo-fractionated stereotactic radiosurgery to spinal lesions. Neurosurgery 2001; 49: 838-846
8. Shaw E, Kline R, Gillin M, Souhami L, Hirschfeld A, Dinapoli R, Martin L. Radiation Therapy Oncology Group: radiosurgery quality assurance guidelines. Int J Radiat Oncol Biol Phys 1993; 27: 1231-1239
9. Loeffler JS, Alexander 3rd E, Hochberg FH, Wen PY, Morris JH, Schoene WC, Siddon RL, Morse RH, Black PM. Clinical patterns of failure following stereotactic interstitial irradiation for malignant gliomas. Int J Radiat Oncol Biol Phys 1990; 19: 455-1462
10. Wong CS, Hao Y. Long-term recovery kinetics of radiation damage in rat spinal cord. Int J Radiat Oncol Biol Phys 1999; 37: 171-179
11. Ang KK, Price RE, Stephens LC, Jiang GL, Feng Y, Schultheiss TE, Peters LJ. The tolerance of primate spinal cord to re-irradiation. Int J Radiat Oncol Biol Phys 1993; 25: 459-464
12. Kogel AJ van der. Dose-volume effects in the spinal cord. Radiother Oncol 1993; 29: 105-109
13. Gerszten PC, Ozhasoglu C, Burton SA, Vogel WJ, Atkins BA, Kalnicki S, Welch WC. CyberKnife frameless stereotactic radiosurgery for spinal lesions: clinical experience in 125 cases. Neurosurgery 2004; 55: 89-98
14. Ryu S, Fang Yin F, Rock J, Zhu J, Chu A, Kagan E, Rogers L, Ajlouni M, Rosenblum M, Kim JH. Image-guided and intensity-modulated radiosurgery for patients with spinal metastasis. Cancer 2003; 97: 2013-2018
15. Dwamena BA, Sonnad SS, Angobaldo JO, Wahl RL. Metastases from non-small cell lung cancer: mediastinal staging in the 1990 s - meta-analytic comparison of PET and CT. Radiology 1999; 213: 530-536
16. Yao M, Graham MM, Hoffman HT, Smith RB, Funk GF, Graham SM, Dornfeld KJ, Skwarchuk M, Menda Y, Buatti JM. The role of post-radiation therapy FDG PET in prediction of necessity for post-radiation therapy neck dissection in locally advanced head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2004; 59: 1001-1010
17. 18FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small-cell lung carcinoma: a prospective study. Int J Radiat Oncol Biol Phys 2002; 52: 339-350
18. Heron DE, Andrade RS, Flickinger J, Johnson J, Agarwala SS, Wu A, Kalnicki S, Avril N. Hybrid PET-CT simulation for radiation treatment planning in head-and-neck cancers: a brief technical report. Int J Radiat Oncol Biol Phys 2004; 60: 1419-1424
19. Erdi YE, Rosenzweig K, Erdi AK, Macapinlac HA, Hu YC, Braban LE, Humm JL, Squire OD, Chui CS, Larson SM, Yorke ED. Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET). Radiother Oncol 2002; 62: 51-60
20. 18F-FDG PET in glioblastoma multiforme: prognostic information and possible role in definition of target volumes in radiation dose escalation. J Nucl Med 2002; 43: 1667-1673
21. 18F]fluorodeoxyglucose positron emission tomography. Ann Neurol 1991; 29: 347-355
22. Chaiken L, Rege S, Hoh C, Choi Y, Jabour B, Julliard G, Hawkins R, Parker R. Positron emission tomography with fluorodeoxyglucose to evaluate tumor response and control after radiation therapy. Int J Radiat Oncol Biol Phys 1993; 27: 455-464
23. Barker FG, Chang SM, Valk PE, Pounds TR, Prados MD. 18-Fluorodeoxyglucose uptake and survival of patients with suspected recurrent malignant glioma. Cancer 1997; 79: 115-126
24. Sasaki M, Kuwabara Y, Yoshida T, Nakagawa M, Fukumura T, Mihara F, Morioka T, Fukui M, Masuda K. A comparative study of thallium-201 SPET, carbon-11 methionine PET and fluorine-18 fluorodeoxyglucose PET for the differentiation of astrocytic tumors. Eur J Nucl Med 1998; 25: 1261-1269
25. 18F]fluoro-2-deoxy-D-glucose. Int J Radiat Oncol Biol Phys 2004; 59: 1295-1300
26. 18F]fluoro-D-glucose with positron emission tomography in patients with esophageal cancer. Mol Imaging Biol 2002; 4: 301-310
27. Koike I, Ohmura M, Hata M, Takahashi N, Oka T, Ogino I, Lee J, Umezawa T, Kinbara K, Watai K, Ozawa Y, Inoue T. FDG-PET scanning after radiation can predict tumor regrowth three months later. Int J Radiat Oncol Biol Phys 2003; 57: 1231-1238
28. Higashi T, Fisher SJ, Brown RS, Nakada K, Walter GL, Wahl RL. Evaluation of the early effect of local irradiation on normal rodent bone marrow metabolism using FDG: preclinical PET studies. J Nucl Med 2000; 41: 2026-2035
29. 18F- fluorodeoxyglucose in patients with stereotactically irradiated brain metastasis. Stereotact Funct Neurosurg 1996; 66: 214-224
30. Lee JK, Liu RS, Shiang HR, Pan DH. Usefulness of semiquantitative FDG-PET in the prediction of brain tumor treatment response to gamma knife radiosurgery. J Comput Assist Tomogr 2003; 27: 525-529